This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Rina Netzwerk Rna Technologien Gmbh, Other. Active years: 2007-2011.
Company Filing History:
1 out of 3 
1 out of 834,307 Years Active: 2007-2011
Title: The Innovative Contributions of Thorsten Lamla
Introduction
Thorsten Lamla is a notable inventor based in Berlin, Germany, recognized for his significant contributions to the field of biotechnology. With a total of two patents under his name, Lamla has demonstrated a strong commitment to advancing scientific understanding and practical applications in genomics and protein technology.
Latest Patents
Thorsten Lamla's latest patents include groundbreaking inventions that hold promise for various biochemical applications. The first patent, focused on a **Streptavidin-binding peptide**, pertains to the development of novel streptavidin binding peptides that enhance the efficiency of biotechnological processes. His second patent, **Method for gene expression**, outlines an innovative approach to gene expression utilizing a cell-free transcription/translation system. This invention encapsulates all essential components for transcription and translation while ensuring that the resulting proteins are immobilized on a matrix, making biochemical experiments more streamlined and effective.
Career Highlights
Throughout his career, Lamla has been associated with prominent companies in the biotechnology sector, including **Rina Netzwerk RNA Technologien GmbH**. His work there and in other capacities has allowed him to make substantial contributions to the understanding and manipulation of RNA technologies, thus paving the way for advancements in genetic engineering and therapeutic applications.
Collaborations
In his professional journey, Thorsten Lamla has collaborated with esteemed colleagues such as Volker A Erdmann and Wolfgang Stiege. Their joint efforts have further enriched the research landscape, enabling the development of innovative solutions aimed at addressing complex biological challenges.
Conclusion
Thorsten Lamla stands out as a pioneering inventor whose work is at the forefront of biotechnology. Through his patents and collaborative efforts, he has significantly contributed to the fields of gene expression and protein engineering, promising potential benefits for various applications in health and science. As he continues to innovate, his contributions will undoubtedly inspire future generations of scientists and inventors seeking to push the boundaries of knowledge and technology.